Corbus Pharmaceuticals Holdings Inc (CRBP.OQ)
CRBP.OQ on NASDAQ Stock Exchange Global Market
7.20USD
5:22pm BST
7.20USD
5:22pm BST
Change (% chg)
$0.02 (+0.28%)
$0.02 (+0.28%)
Prev Close
$7.18
$7.18
Open
$6.98
$6.98
Day's High
$7.20
$7.20
Day's Low
$6.77
$6.77
Volume
194,978
194,978
Avg. Vol
196,681
196,681
52-wk High
$9.85
$9.85
52-wk Low
$4.53
$4.53
About
Corbus Pharmaceuticals Holdings, Inc. is a Phase-III, clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company operates through developing and commercializing therapeutics to treat rare... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | $371.63 |
| Shares Outstanding(Mil.): | 50.22 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CRBP.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 85.35 | 33.64 |
| EPS (TTM): | -0.60 | -- | -- |
| ROI: | -100.08 | 0.18 | 14.27 |
| ROE: | -100.21 | 1.14 | 15.99 |
BRIEF-Corbus Pharmaceuticals Reports Q1 Loss Per Share $0.21
* CORBUS PHARMACEUTICALS REPORTS 2018 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Estimates